Moreover, in vivo administration of TGF−β as a drug in the presence of high IL−6 levels in lupus could induce pathogenic Th17 cells and TFH cells, instead of generating Treg cells (128, 129). The gene discussed is IL6; the disease is systemic lupus erythematosus.